Kamal Kamal Gadalla, Ph.D.
Mean distance: 17.42 (cluster 6)
ChildrenSign in to add trainee
CollaboratorsSign in to add collaborator
BETA: Related publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
|Powers S, Likhite S, Gadalla KK, et al. (2023) Novel MeCP2 Gene Therapy is Effective in a Multicenter Study using Two Mouse Models of Rett Syndrome and is Safe in Non-human Primates. Molecular Therapy : the Journal of the American Society of Gene Therapy|
|Gadalla KK, Ross PD, Riddell JS, et al. (2014) Gait analysis in a Mecp2 knockout mouse model of Rett syndrome reveals early-onset and progressive motor deficits. Plos One. 9: e112889|
|Gadalla KK, Bailey ME, Spike RC, et al. (2013) Improved survival and reduced phenotypic severity following AAV9/MECP2 gene transfer to neonatal and juvenile male Mecp2 knockout mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 18-30|
|Gadalla KK, Bailey ME, Cobb SR. (2011) MeCP2 and Rett syndrome: reversibility and potential avenues for therapy. The Biochemical Journal. 439: 1-14|